Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEAL-PCI Registry
NCT01515345Phase 3Completed
- Sponsor
- Klinik Favoriten
- Start
- Jul 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prasugrel, ticagrelor in coronary artery disease (CAD), sponsored by Klinik Favoriten. Started Jul 2011; status: completed.
02
Drugs
prasugrelticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01515345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01515345.